Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"
NCT05103644
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Atorvastatin 80mg
OTHER:
placebo
Sponsor
Beni-Suef University